RxDoctor Payments Data

Shivangi Kothari

Gastroenterology · Rochester, NYNPI 1588829089

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $55,806 of the $78,959 with a category attached, or 70.7%. Boston Scientific accounts for 65.7% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2024 at $22,419 and has fallen 79.0% since, to $4,712 in 2025. Among gastroenterology clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$78,959in general payments, 2019–2025

Across 83 payments — averaging $951.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$52K
  • Olympus Corporation Of The Americas$11K
  • Olympus America Inc.$8K
  • Conmed Corporation$4K
  • Wilson Cook Medical Incorporated$3K
  • Medtronic$828
  • plus $407 from 3 others
$12,755in research payments, 2019–2025

Across 1 payment — averaging $12,755 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AbbVie$13K

What the payments were for

  • Consulting fees$5,5397%
  • Speaking & faculty fees$55,80671%
  • Travel & lodging$3,8105%
  • Food & beverage$2,3493%
  • Education$11,45515%

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$78,959 in reported general payments places this provider in the 90th percentile of 1,682 gastroenterology providers in New York.

See all gastroenterology providers in New York →

Medicare billing

Part B allowed, 2024
$33,457
Medicare patients
138
Services billed
233

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Sucralfate13$1,656
Omeprazole52$776
Ciprofloxacin Hcl13$29

Paid to pharmacies, not to this prescriber.

Other gastroenterology in Rochester

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →